October 2024 in “Journal of the Endocrine Society” In this case report, a 70-year-old woman with a history of autoimmune hypothyroidism experienced alternating hypothyroidism and hyperthyroidism over a decade, highlighting the potential role of thyrotropin receptor autoantibodies in these fluctuations.
August 2024 in “Journal of Cosmetic Dermatology” This study investigates differences in nutritional status, vitamin, and mineral levels between individuals with telogen effluvium and a control group, aiming to understand the nutritional factors involved in this condition.
July 2024 in “Journal of Investigative Dermatology” Topical thyroid hormones may boost hair growth.
July 2024 in “Journal of Investigative Dermatology” Human hair follicles have their own thyroid hormone system.
July 2024 in “International Journal of Chemical and Biological Sciences” This study reported that women with polycystic ovary syndrome had higher glypican-4 levels compared to controls, indicating its significant role in hormonal regulation associated with the condition.
June 2024 in “Biological and Clinical Sciences Research Journal” In this study, researchers found that women with PCOS and thyroid dysfunction had significantly altered T3 and T4 hormone levels and more frequent symptoms like weight gain and irregular menstrual cycles, suggesting the importance of thyroid screenings for personalized treatment strategies.
This study suggests that topically applied thyroid hormones T3 and T4 promote hair growth on human scalp tissues ex vivo, highlighting potential therapeutic use for hair loss conditions like androgenetic alopecia.
May 2024 in “Drug discovery today” This review discusses the potential role of thyroid receptor β agonists in treating androgenetic alopecia, reporting no new clinical results while highlighting their mechanism and anti-alopecia efficacy.
April 2024 in “DAHUDER Medical journal” This study examined the relationship between thyroid autoimmunity and alopecia areata in patients aged 2-65 and found no statistically significant association, despite a notable correlation between anti-TPO levels and disease duration.
This observational study reviewed thyroid eye disease patients treated with teprotumumab at one center, reporting common side effects like fatigue and dry eye symptoms, with serious adverse events including two cases of blood clots and one pulmonary embolism.
February 2024 in “Folia Medica” In this study, PRP therapy showed effectiveness in treating mild to moderate alopecia areata in patients with normal antithyroid antibodies, while those with severe forms or elevated antibodies did not experience significant benefits.
February 2024 in “International Journal of Research in Dermatology” In this study, researchers examined thyroid function and autoantibody levels in patients with alopecia areata and vitiligo, finding similar rates of thyroid dysfunction and autoantibody presence in both groups, with no significant differences based on ethnicity or gender.
January 2024 in “Indian Journal of Pharmacy Practice” This study examined 142 patients with subclinical thyroid disorders and found a high incidence of comorbidities like renal diseases. Researchers reported that good medication adherence was associated with better quality of life, indicating a significant relationship between adherence and quality of life.
January 2024 in “International Journal of Medicine in Developing Countries” This study in Alahsa, Saudi Arabia, found that the majority of the general population has limited awareness of thyroid disease symptoms and risk factors, with only 21.8% demonstrating good knowledge about the disorders.
January 2024 in “International journal of chemical research and development (Print)” This study found significant associations between reduced levels of vitamin B12, zinc, and other vitamins, and the occurrence of hair loss in women with alopecia.
January 2024 in “African Journal of Biomedical Research” In this study of pregnant women in Pampore, Kashmir, 90% were found to have hypothyroidism, with 75% of thyroid dysfunction cases being diagnosed during pregnancy. The study highlights the need for better nutrition and early screening to manage gestational thyroid dysfunction effectively.
November 2023 in “Ibrahim Cardiac Medical Journal” This study observed that patients with alopecia areata have a significantly higher prevalence of thyroid disorders and elevated levels of thyroid-stimulating hormone and thyroid auto-antibodies compared to healthy individuals, with a 4.7 times greater risk of thyroid dysfunction among alopecia areata patients.
November 2023 in “International Journal of Trichology” This study, conducted at a tertiary care hospital, found no statistically significant association between male pattern hair loss and levels of serum ferritin or thyroid-stimulating hormone, suggesting these factors may not play a role in this condition.
October 2023 in “Clinical medicine and medical research” This study indicates that higher thyroid-stimulating hormone levels may be linked to post-COVID-19 hair loss in women, while ferritin levels showed no significant correlation.
September 2023 in “Medical and Clinical Case Reports” This source explores the association between alopecia areata and thyroid dysfunction, highlighting a particularly strong link with Hashimoto thyroiditis and hypothyroidism.
This study reviewed existing literature to demonstrate that thyroid disorders have a significant and underestimated impact on hair loss, highlighting gaps in current knowledge and the need for further research to better diagnose and manage hair disorders linked to thyroid dysfunction.
This study found a significant association between higher serum anti-thyroperoxidase (anti-TPO) antibody levels and the occurrence of chronic spontaneous urticaria, suggesting that testing for anti-TPO antibodies alongside primary thyroid markers might be important in managing this condition.
This study observed that individuals with autoimmune thyroid disease in Georgia had significantly higher frequencies of certain symptoms and Anti-TPO levels compared to controls, with no significant difference in vitamin D levels.
February 2023 in “European journal of geriatrics and gerontology” Selenium helps prevent thyroid issues and cognitive decline in the elderly, but balance is key.
October 2022 in “The Egyptian Journal of Hospital Medicine” This study found that thyroid dysfunctions were present in a significant number of women with diffuse hair loss, suggesting the importance of investigating thyroid functions in these patients.
May 2022 in “Endocrine practice” This case report illustrates that high-dose biotin supplementation can cause false thyroid function test abnormalities in vitro, emphasizing the need to assess biotin intake before testing.
This article discusses functional thyroid disorders, their symptoms, and causes, without presenting new clinical results; it describes hypothyroidism and hyperthyroidism manifestations and explores the prevalence of thyroid nodules.
February 2022 in “Endocrine connections” This review summarizes existing research on how various endocrinopathies, including reproductive disorders and thyroid conditions, can affect vocal parameters, and reports no new clinical findings.
January 2022 in “Indian journal of dermatopathology and diagnostic dermatology” This study observed that low serum ferritin and vitamin D levels may contribute to diffuse hair loss in women.
July 2021 in “Al-Azhar Assiut Medical Journal” This study found that women with telogen effluvium had significantly lower serum ferritin and vitamin D levels compared to controls, suggesting these could be diagnostic biomarkers for the condition.